ICTD 2022: a Successful hybrid event on Patient Recruitment
ICTD 2022 - Recruitment in Clinical Trials
ECRIN, together with our German national partner, the KKS Netzwerk, hosted International Clinical Trials Day 2022 as a hybrid event located in Berlin.
ECRIN Annual Report 2021
We are very proud to present to you the ECRIN Annual Report 2021! As you may notice right away, the Annual Report is presented to you in an entirely new format. Namely, the size changed from an A4 to a square format, so that it will better fit your screens.
SYNCHROS: Setting priorities beyond the end of the project
In June 2022, after 42 months of extensive work from the 11 consortium partners, SYNCHROS (SYNergies for Cohorts in Health: integrating the Role of all Stakeholders) is coming to an end.
PERMIT final meeting: so long, not goodbye
On June 16th and 17th the PERMIT project consortium, personalised medicine experts and other invested stakeholders met in Milan (and online) at the Istituto di Recherche Farmacologiche Mario Negri to discuss the recommendations that were developed over the 2.5 years of the project.
SIMCor project teaser video
The SIMCor project is developing a computational platform for in-silico testing and validation of cardiovascular implantable devices. How this works?
Launch of 2022 Data Centre Certification Call
The call for application to ECRIN Data Centre Certification Programme is open until the 23 September 2022.
Questionnaire to inform a European multinational clinical project proposal training
ECRIN and its national partners are working on a training series that will focus on supporting researchers to develop proposals for European calls that are open to mult
Funding available for ECRIN services through ISIDORe TNA Open Call
ISIDORe just launched the first call for transnational access for projects focusing on SARS-CoV-2 and COVID-19 research. ISIDORe TNA programme aims at supporting scientists by providing them access (physical, remote, or virtual) to facilities, equipment, expertise, services and resources that the
TransVac Open Call for Applications
TRANSVAC2, an European vaccine research and development (R&D) infrastructure project, is dedicated to accelerating the development of safe, effective and affordable vaccines.
ECRIN: Opening doors to European Clinical Research (VIDEO)
ECRIN supports clinical trials across borders. How do we do that? We are very proud to show it to you in our brand new video!
The first academic multinational clinical trial approval using CTIS
The EU-SolidAct trial, previously authorized under the EU CT Directive 2001/20/EC, has been successfully transferred and is authorized under the new EU regulation (Regulation (EU) No 536/2014) in 12 countries.
EUPATI Fundamentals patient engagement training
After more than 2 years, our partner EUPATI organises the Fundamentals in a face to face session. EUPATI Fundamentals is a training about Patient Engagement addressed to professionals in academia and pharmaceutical industry.
MACUSTAR receives Letter of Support from EMA
The MACUSTAR project has received a second Letter of Support from the European Medicines Agency (EMA) for its work on new measures to assess the eye disease age-related macular degeneration in clinical trials.
EU-AMRI launched in Brussels
EU-AMRI, the European Alliance of Medical Research Infrastructures, was officially launched during a live broadcast from Brussels on 5 April 2022.
Clinical trial success relies on effective patient recruitment – International Clinical Trials Day 2022
International Clinical Trial Day 2022 will be co-hosted by ECRIN (European Clinical Research Infrastructure Network) and its German scientific partner KKS-Netzwerk (the Network of Coordinating Centres for Clinical Trials) on May 17th 2022, and this years’ theme is Recruitment in Clinical Trials.
PERMIT Implementation workshop
On 17 March, the PERMIT project held its Implementation Workshop.
ISIDORe kick off meeting
ISIDORe – “Integrated Services for Infectious Disease Outbreak Research” was officially launched on the 24 February 2022.
PERMIT 4th General Assembly
The PERMIT project hosted its 4th General Assembly on 4 February 2022. With the approval of the 6-month no-cost extension of the project, this meeting marks the beginning of the home stretch for the project. Each work package presented the actions carried out since July 2021.